Arkolith/Insider Trading/NBY/Form 4

Kazley Michael John

Chief Executive Officer, Director, 10% OwnerNovaBay Pharmaceuticals, Inc. (NBY) · full profile →Form 4 · filed Oct 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 16, 2025Grant(A)221K—$0221K
Oct 16, 2025Grant(A)134K—$0134K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-25-008289) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML